WESLEY FERRILL: Open Payments
NPI 1134833379 · SPRINGFIELD, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$931 in 61 payments from 9 companies in 2025. Trend: 2023 $37 · 2024 $956 · 2025 $931
Food & beverage: $931
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 11 | $293 |
| Novartis Pharmaceuticals Corporation | 39 | $285 |
| Novo Nordisk Inc | 4 | $166 |
| SCPHARMACEUTICALS INC. | 1 | $60 |
| Alnylam Pharmaceuticals Inc. | 2 | $55 |
| Merck Sharp & Dohme LLC | 1 | $20 |
| PFIZER INC. | 1 | $20 |
| E.R. Squibb & Sons, L.L.C. | 1 | $19 |
| Boston Scientific Corporation | 1 | $14 |
Products named: REPATHA, LEQVIO, Wegovy, FUROSCIX, AMVUTTRA, ENTRESTO, VERQUVO, ELIQUIS.
Industry payments across IL — which companies pay providers there.
